Intercept Pharmaceuticals - Business Information

Manufacturing · New Jersey, United States · 341 Employees

Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases. Its lead product candidate is obeticholic acid (OCA), a bile acid analog, which has a structure based on a naturally occurring human bile acid that selectively binds to and activates the farnesoid X receptor (FXR). The company is developing OCA to treat various non-viral progressive liver diseases, such as nonalcoholic steatohepatitis, primary sclerosing cholangitis, and biliary atresia. It also provides OCA under the Ocaliva brand name for the treatment of primary biliary cholangitis in the United States and Europe. In addition, the company is developing INT-767, an orally administered dual FXR and TGR5 agonist for the treatment of liver fibrosis; and INT-777, an orally administered TGR5 agonist for the treatment of type 2 diabetes, associated metabolic disorders, and other gastrointestinal indications. Intercept Pharmaceuticals, Inc. was founded in 2002 and is headquartered in New York, New...Read More

View Company Info for Free

Who is Intercept Pharmaceuticals

Headquarters

305 Madison Ave, Morristown, New Jersey, 07960, United States

Phone Number

(646) 747-1000

Website

www.interceptpharma.com

Revenue

$285.7M

Stock Symbol

ICPT

Industry

Pharmaceuticals

Healthcare

Is this data correct?

View contact profiles from Intercept Pharmaceuticals

Popular SearchesIntercept Pharmaceuticals IncInterCept IncIntercept PharmaceuticalsIntercept Technology IncInterceptSIC Code 28,283NAICS Code 32,325Ticker NASDAQ: ICPTShow More

Top Competitors of Intercept Pharmaceuticals

Atara Biotherapeutics
570
$24.1M
1
Global Blood Therapeutics
457
$210.9M
2
Epizyme Inc
250
$38.5M
3
Ascentage Pharma
238
$80.9M
4
Sorrento Therapeutics Inc
949
$60.3M
5
Amicus Therapeutics Inc
496
$317.8M
6

Intercept Pharmaceuticals Org Chart

View Intercept Pharmaceuticals org chart to access information on key employees and get valuable insights about Intercept Pharmaceuticals organizational structure. The organizational chart highlights the reporting lines within the company, starting with Raffi Alexanian - the Intercept Technologies Founder & Chief Executive Officer of Intercept Pharmaceuticals, and followed by additional decision makers: Anindita Sinha, Vice President, Chief of Staff To the Chief Executive Officer, and Rachel Bernard, Vice President Chief Of Staff Office Of The Chief Executive Officer.

Raffi Alexanian

Intercept Technologies Found...

Phone

Anindita Sinha

Vice President, Chief of Sta...

Phone

Rachel Bernard

Vice President Chief Of Staf...

Phone

View Email Formats for Intercept Pharmaceuticals

Intercept Pharmaceuticals Company Metrics

Company Insights

Employee Growth Rate

Funding

Funding DateMay 10, 2019

RoundStock Issuance/Offering

Amount$200M

Investors

Funding DateMay 10, 2019

RoundDebt

Amount$210.4M

Investors

Funding DateApr 05, 2018

RoundStock Issuance/Offering

Amount$250M

InvestorsSamsara BioCapital, L.P., Genextra S.p.A

$1.5B

Total Funding Amount

$200M

Most Recent Funding Amount

Number of Funding Rounds

Top Companies in United States

View leading companies in United States by different categories: revenue, number of employees and funding amount. Top companies in United States by revenue is Walmart, by number of employees is Tip Top Poultry and by funding amount is American Airlines. See full lists for all leading companies and additional company information such as contact details, org chart, industry, employees and more.

Intercept Pharmaceuticals News & Media

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Intercept Pharmaceuticals, Inc. Buyout
Wilmington, Delaware--(Newsfile Corp. - September 26, 2023) - Rigrodsky Law, P.A. is investigating Intercept Pharmaceuticals, Inc. ("Intercept") (NASDAQ: ICPT) regarding possible breaches of fiduciary duties and other violations of law related to Intercept's agreement to be acquired by Alfasigma S.p.A. Under the terms of the agreement, Intercept shareholders will receive $19.00 per share in cash.To learn more about this investigation and your rights, visit:...
Sep 26, 2023
www.newsfilecorp.com
Alfasigma Buys Beleaguered Intercept Pharmaceuticals in $800M Cash Deal - BioSpace
The Italian pharma company is acquiring what was once one of the hottest stocks in the biotech sector, just months after the FDA rejected Intercept’s non-alcoholic steatohepatitis candidate.
Sep 26, 2023
www.biospace.com
ICPT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Intercept Pharmaceuticals, Inc. Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) to Alfasigma S.p.A. for $19.00 per share in cash is fair to Intercept shareholders. Halper Sadeh encourages Intercept shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns wheth
Sep 26, 2023
www.businesswire.com
Intercept Pharmaceuticals to Conduct Fireside Chats and One-on-One Meetings at ...
Sep 5, 2023
ir.interceptpharma.com
Intercept Cuts All NASH Investments, One-Third of Staff After Second FDA Rejection
The FDA has again denied Intercept’s bid to have its obeticholic acid tablets approved in non-alcoholic steatohepatitis, forcing the company to abandon the indication and restructure operations.
Jun 24, 2023
www.biospace.com

Frequently Asked Questions regarding Intercept Pharmaceuticals

Where is Intercept Pharmaceuticals located?

Intercept Pharmaceuticals's headquarters are located at 305 Madison Ave, Morristown, New Jersey, 07960, United States

What is Intercept Pharmaceuticals's phone number?

Intercept Pharmaceuticals's phone number is (646) 747-1000

What is Intercept Pharmaceuticals's stock symbol?

Intercept Pharmaceuticals's stock symbol is ICPT

What is Intercept Pharmaceuticals's official website?

Intercept Pharmaceuticals's official website is www.interceptpharma.com

What is Intercept Pharmaceuticals's Revenue?

Intercept Pharmaceuticals's revenue is $285.7 Million

What is Intercept Pharmaceuticals's SIC code?

Intercept Pharmaceuticals's SIC: 28,283

What is Intercept Pharmaceuticals's NAICS code?

Intercept Pharmaceuticals's NAICS: 32,325

How many employees does Intercept Pharmaceuticals have?

Intercept Pharmaceuticals has 341 employees

What industry does Intercept Pharmaceuticals belong to?

Intercept Pharmaceuticals is in the industry of: Pharmaceuticals, Healthcare

What is Intercept Pharmaceuticals competition?

Intercept Pharmaceuticals top competitors include: Atara Biotherapeutics, Global Blood Therapeutics, Epizyme Inc, Ascentage Pharma

Who is the CEO of Intercept Pharmaceuticals?

Intercept Pharmaceuticals's CEO is Jerome Durso

Who is the CFO of Intercept Pharmaceuticals?

Intercept Pharmaceuticals's CFO is Andrew Saik

How do I contact Intercept Pharmaceuticals?

Intercept Pharmaceuticals contact info: Phone number: (646) 747-1000 Website: www.interceptpharma.com

What does Intercept Pharmaceuticals do?

What are Intercept Pharmaceuticals social media links?

Intercept Pharmaceuticals Linkedin page Intercept Pharmaceuticals Facebook page Intercept Pharmaceuticals Twitter page

How much funding has Intercept Pharmaceuticals raised to date?

Intercept Pharmaceuticals has raised $1.5 Billion in 11 funding rounds

When was the last funding round for Intercept Pharmaceuticals?

Intercept Pharmaceuticals closed its last funding round on May 10, 2019 with the amount of $200 Million

Who invested in Intercept Pharmaceuticals?

Intercept Pharmaceuticals has 15 investors including JAFCO Life Science Investment, Genextra S.p.A, Balyasny Asset Management and Rodman & Renshaw.

Is Intercept Pharmaceuticals a public company?

Yes, Intercept Pharmaceuticals is a public company and is traded under the symbol ICPT

See more information about Intercept Pharmaceuticals

Intercept Pharmaceuticals has 341 employees. View the comprehensive list of Intercept Pharmaceuticals employees, their locations, business contact details and key personnel.

Find more contacts